Herein we report the design of two new titanium metal–organic frameworks (MOFs), Ti 3 -BPDC-Ir and Ti 3 -BPDC-Ru, by doping [Ir(ppy) 2 (dcbpy)]Cl or [Ru(bpy) 2 (dcbpy)]Cl 2 (bpy = 2,2′-bipyridine, ppy = 2-phenylpyridine, dcbpy = 2,2′-bipyridine-5,5′-dicarboxylate) into the Ti 3 -BPDC framework (BPDC = biphenyl-4,4′-dicarboxylate). Hierarchical assembly of photosensitizing ligands and Ti 3 (OH) 2 secondary building units (SBUs) facilitates multielectron transfer to drive photocatalytic hydrogen evolution (HER) under visible light with turnover numbers of 6632 and 786 for Ti 3 -BPDC-Ir and Ti 3 -BPDC-Ru, respectively. Photophysical and electrochemical studies establish the photocatalytic HER via reductive quenching of the excited photosensitizers followed by electron transfer from the reduced photosensitizers to Ti 3 (OH) 2 SBUs and explain the catalytic difference between the two MOFs. Density functional theory calculations reveal key steps of HER via protonation of Ti III –OH to generate the Ti III species with a vacant coordination site followed by proton-coupled electron transfer to afford the key Ti IV –H intermediate.
No takes yet. Share an insight, caveat, or question.
Song et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: